Abstract 1542: ALK expression identifies a therapeutically targetable subset of Merkel cell carcinomas responsive to ALK.CAR-T cell therapy alone or in combination with ALK inhibitors
Alessandro Gasparetto, Jasna Metović, Elisa Landoni, Carmen Mecca et autres
Abstract Background: Merkel cell carcinoma (MCC) is a rare and highly aggressive neuroendocrine skin cancer with limited treatment options. While chemo-immunotherapy remains the standard of care, nearly 50% of patients experience disease progression, with a median overall survival of 10 months. Anaplastic …
us, it (code pays fourni par la source)
0 citations
Cancer Research